Arvee Laboratories (India) quarterly results and financials

Arvee Laboratories (India) (ARVEE)₹227.59−3.18%(9 Nov 2026 close)Specialty Chemicals

Key facts

In the Jun 2026 quarter (standalone), Arvee Laboratories (India) reported sales of ₹17.16 Cr, up 130.3% from Jun 2025, and net profit of ₹1.70 Cr, up 844.4% year on year. For the year to Mar 2026, sales were ₹31.40 Cr and net profit ₹2.54 Cr.

Sales (Jun 2026): ₹17.16 Cr
Net profit (Jun 2026): ₹1.70 Cr
Sales (FY Mar 2026): ₹31.40 Cr
Net profit (FY Mar 2026): ₹2.54 Cr
EPS (Jun 2026): ₹1.54
Borrowings (Mar 2026): ₹1.10 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Arvee Laboratories (India) quarterly results

₹ crore unless stated; each column is a quarter.

Arvee Laboratories (India) Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	8.87	7.68	6.11	10.57	12.48	8.88	6.42	7.45	3.44	9.74	10.76	17.16
Expenses	8.21	7.16	5.34	9.05	11.02	8.56	6.22	7.13	3.32	8.14	9.69	14.73
Operating Profit	0.68	0.52	0.78	1.53	1.49	0.33	0.21	0.33	0.11	1.62	1.09	2.48
OPM %	7.8%	6.9%	12.9%	14.6%	12.0%	3.8%	3.4%	4.6%	3.5%	16.7%	10.2%	14.5%
Other Income	0.08	0.18	0.20	0.10	0.15	0.18	0.20	0.16	0.22	0.13	0.14	0.17
Interest	0.07	0.06	0.06	0.09	0.06	0.06	0.08	0.05	0.03	0.08	0.07	0.05
Depreciation	0.43	0.36	0.38	0.32	0.31	0.29	0.28	0.30	0.31	0.31	0.32	0.33
Profit before tax	0.27	0.31	0.57	1.25	1.30	0.19	0.08	0.17	0.00	1.39	0.85	2.28
Tax %	25.0%	25.1%	81.1%	25.5%	25.2%	25.0%	22.3%	5.6%	0.0%	−30.6%	38.5%	26.3%
Net Profit	0.22	0.25	0.13	0.95	0.99	0.16	0.08	0.18	0.02	1.84	0.53	1.70
EPS (Rs)	0.20	0.23	0.12	0.86	0.90	0.15	0.07	0.16	0.02	1.67	0.48	1.54

Arvee Laboratories (India) profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Arvee Laboratories (India) Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	26.73	34.30	47.65	54.67	45.24	47.19	40.21	61.16	30.22	38.34	31.40	41.10
Expenses	21.82	28.53	40.62	48.74	39.39	41.30	34.64	54.02	27.40	34.87	28.31	35.88
Operating Profit	4.97	5.89	7.15	6.16	6.00	6.05	5.66	7.28	2.93	3.60	3.18	5.30
OPM %	18.7%	17.2%	15.0%	11.3%	13.3%	12.9%	14.1%	11.9%	9.7%	9.4%	10.1%	12.9%
Other Income	0.09	0.50	0.22	0.34	0.34	0.55	0.45	1.34	0.63	0.65	0.67	0.66
Interest	3.06	3.47	3.34	1.64	0.98	0.59	0.38	0.40	0.26	0.26	0.22	0.23
Depreciation	1.50	2.08	2.16	2.36	2.30	2.42	2.33	2.09	1.51	1.16	1.22	1.27
Profit before tax	0.52	0.85	1.91	2.53	3.08	3.63	3.44	6.16	1.82	2.86	2.42	4.52
Tax %	66.1%	−81.4%	43.3%	11.1%	25.9%	26.4%	25.6%	33.3%	42.7%	25.1%	−3.7%	—
Exceptional items	0.00	0.00	0.00	0.07	0.13	0.18	0.08	0.00	0.03	0.09	0.00	—
Net Profit	0.20	1.56	1.10	2.27	2.31	2.69	2.58	4.13	1.06	2.16	2.54	4.09
EPS (Rs)	0.24	1.92	1.00	2.06	2.10	2.44	2.34	3.75	0.96	1.96	2.31	3.71
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Arvee Laboratories (India) balance sheet

₹ crore, at each year end.

Arvee Laboratories (India) Balance sheet
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4.04	4.04	5.50	5.50	5.50	11.00	11.00	11.00	11.01	11.00	11.01
Reserves	−1.40	0.14	8.67	10.94	13.23	10.39	12.90	17.00	18.05	20.20	22.73
Borrowings	25.24	24.92	16.10	12.83	3.86	8.86	3.12	0.99	0.99	1.02	1.10
Other Liabilities	7.26	6.51	13.73	7.81	10.98	10.72	11.56	9.59	8.43	5.26	8.32
Total Liabilities	35.14	35.61	44.00	37.08	33.57	40.97	38.58	38.58	38.48	37.48	43.16
Fixed Assets	13.13	16.86	14.85	12.64	13.17	13.79	13.82	12.65	12.66	15.26	16.70
CWIP	4.29	0.00	1.17	2.31	1.77	0.96	0.97	1.52	2.61	0.72	0.89
Investments	0.00	0.00	0.00	1.96	3.10	2.04	0.00	0.00	0.00	0.00	0.00
Other Assets	17.72	18.75	27.98	20.17	15.53	24.18	23.79	24.41	23.21	21.50	25.57
Inventories	7.09	6.24	8.18	4.63	6.49	7.45	5.75	4.58	6.42	4.56	9.22
Trade receivables	6.08	8.23	15.49	7.93	6.53	7.89	12.14	12.28	6.12	8.41	10.46
Cash & equivalents	1.24	0.95	1.96	3.64	0.97	6.60	4.62	0.88	1.86	4.90	3.27
Total Assets	35.14	35.61	44.00	37.08	33.57	40.97	38.58	38.58	38.48	37.48	43.16

Arvee Laboratories (India) cash flow

₹ crore, for each year.

Arvee Laboratories (India) Cash flow
	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	4.02	6.01	9.43	10.28	1.70	0.67	2.92	3.65	−0.20	−0.11
Cash from investing activity	−1.39	−1.22	−2.84	−3.07	−0.59	0.05	−1.25	−2.15	−1.31	0.49
Cash from financing activity	−2.91	−3.77	−4.91	−9.87	4.51	−6.04	−2.41	−0.18	−0.11	−0.15
Net cash flow	−0.30	1.01	1.69	−2.68	5.64	−5.33	−0.76	1.32	−1.65	0.24
Capex	1.51	1.33	1.49	2.28	2.28	2.35	1.47	2.58	1.84	2.82
Free cash flow	2.53	4.67	7.94	8.00	−0.52	−1.67	1.46	1.06	−2.05	−2.94
CFO / OP %	57.0%	96.0%	158.0%	184.0%	44.0%	29.0%	64.0%	139.0%	10.0%	3.0%

Arvee Laboratories (India) ratios

Working-capital days and returns, by year.

Arvee Laboratories (India) Ratios
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	84	88	119	54	53	62	111	74	74	81	122
Inventory days	154	104	99	42	80	91	92	41	158	79	228
Days payable	131	98	150	56	126	118	160	73	164	58	159
Cash conversion cycle	107	94	68	40	8	35	43	42	68	102	191
Working capital days	31	32	32	−6	11	−10	51	71	97	105	168
ROCE %	—	15.2%	17.7%	13.7%	14.9%	15.0%	12.9%	23.4%	6.8%	9.6%	8.0%

Arvee Laboratories (India): frequently asked questions

What are the latest quarterly results of Arvee Laboratories (India)?

For the Jun 2026 quarter, Arvee Laboratories (India) reported sales of ₹17.16 Cr, up 130.3% year on year and net profit of ₹1.70 Cr, up 844.4% year on year. The operating margin was 14.5%.

What is the annual revenue of Arvee Laboratories (India)?

Arvee Laboratories (India)'s sales for the year to Mar 2026 were ₹31.40 Cr; over the last twelve months they were ₹41.10 Cr.

What is the net profit of Arvee Laboratories (India)?

Net profit for the year to Mar 2026 was ₹2.54 Cr, and ₹4.09 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.71.

How much debt does Arvee Laboratories (India) have?

Arvee Laboratories (India) reported borrowings of ₹1.10 Cr at Mar 2026, against cash and equivalents of ₹3.27 Cr.

What is the free cash flow of Arvee Laboratories (India)?

Cash from operations was −₹0.11 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹2.94 Cr.

Loading…